The registration process for generic drugs in Taiwan is regulated by the Taiwan Food and Drug Administration (TFDA). This process ensures that generic drugs meet safety, efficacy, and quality standards...... Read More
Author: DDRegpharma
In the global pharmaceutical market, ensuring drug safety through proper pharmacovigilance practices is paramount. Regulatory agencies around the world mandate robust systems to monitor, assess, and report adverse drug reactions...... Read More
India’s medical device market is one of the fastest growing in the world, According to Invest India, India’s medical device market valued at around USD 11 billion in 2022–23, is projected to reach...... Read More
Pharmacogenomics lies at the intersection of genetic science, clinical pharmacology, and regulatory strategy. It’s enabling the transition from conventional, trial-and-error prescribing to precision-driven, patient-specific therapies. As the demand for personalized...... Read More
Connected medical devices—from insulin pumps to remote monitoring systems—are transforming healthcare. But they also open doors to cyber threats. Protecting patient data and ensuring device safety requires regulatory compliance, robust...... Read More
China’s pharmaceutical market is booming, but success requires more than just a strong drug—it demands navigation of a unique regulatory landscape. Understanding the National Medical Products Administration (NMPA), leveraging real-world...... Read More
Real-world data (RWD) is transforming drug development by complementing traditional clinical trials with evidence from actual patient experiences. Health records, insurance claims, wearable devices, and patient registries provide insights into...... Read More
The healthcare sector is evolving rapidly, and trends in medical devices are at the center of this transformation. From smart monitoring systems to AI-powered diagnostics, new technologies are improving patient...... Read More
The rise of biosimilars has reshaped modern medicine by offering affordable alternatives to biologics. But with increased adoption comes the critical responsibility of ensuring patient safety. In 2025, regulators, manufacturers,...... Read More
Drug Registration in Brazil is a critical step for pharmaceutical companies aiming to access Latin America’s largest healthcare market. ANVISA, Brazil’s regulatory authority, oversees the entire approval process. Understanding its...... Read More